Dr. Margaret Lamb, MD
Claim this profileStudies Non-Hodgkin's Lymphoma
Studies Acute Lymphoblastic Leukemia
1 reported clinical trial
1 drug studied
More about Margaret Lamb, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Margaret Lamb, MD has experience with
- CD19 Specific Chimeric Antigen Receptor T Cell
Breakdown of trials Margaret Lamb, MD has run
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
B-Cell Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret Lamb, MD specialize in?
Margaret Lamb, MD focuses on Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia. In particular, much of their work with Non-Hodgkin's Lymphoma has involved CD19 positive patients, or patients who are undergoing treatment.
Is Margaret Lamb, MD currently recruiting for clinical trials?
No, Margaret Lamb, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Margaret Lamb, MD has studied deeply?
Yes, Margaret Lamb, MD has studied treatments such as CD19 specific Chimeric Antigen Receptor T Cell.
What is the best way to schedule an appointment with Margaret Lamb, MD?
Apply for one of the trials that Margaret Lamb, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.